Back to 
NEW YORK LIFE INVESTMENT MANAGEMENT LLC
NEW YORK LIFE INVESTMENT MANAGEMENT LLC
BHVN
Showing 0 of 3 quarters
Position history for NEW YORK LIFE INVESTMENT MANAGEMENT LLC's holdings in BIOHAVEN PHARMACEUTICAL HOLD
As of its Q3 2022 13F, New York Life Investment Management held 142,048 shares of BHVN (Biohaven Pharmaceutical Hold), worth $21.5M. New York Life Investment Management's 13F filings listed BHVN from Q2 2022 to Q3 2022, 2 quarterly filings. BHVN was 0.3% of New York Life Investment Management's reported 13F portfolio.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.